curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Undergraduate Nursing Intern Cohort Study

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Occupational Disidentification Sponsors: Nanjing Medical University Recruiting Conditions: Occupational Disidentification Sponsors: Nanjing Medical University Recruiting 

Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Type 1 Diabetes Interventions: Other: Intensive lifestyle modification (hypocaloric Mediterranean diet and promotion of physical activity); Dietary Supplement: Butyrate; Dietary Supplement: Intensive lifestyle modification + butyrate Sponsors: Fundación...

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease; Mucosal Ulcerations Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease;...

Extended Post-operative Oral TXA in Primary THA

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Osteoarthritis (OA) of the Hip; Osteoarthritis (OA) of the Knee Interventions: Drug: Extended oral tranexamic acid regimen; Drug: Placebo Sponsors: Oregon Health and Science University Not yet recruiting Conditions: Osteoarthritis (OA) of the Hip;...

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd Not yet recruiting Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors:...
« Older Entries
Next Entries »

Recent Posts

  • TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman
  • Vagus Nerve Stimulation in Patients in Comatose State
  • CITE: Clinical Inference Tethered to Evidence – a Retrieve-and-verify Layer for AI Care Plans
  • Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
  • Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®